Advertisement
Advertisement
U.S. Markets close in 2 hrs 48 mins
Advertisement
Advertisement
Advertisement
Advertisement

Valneva SE (VALN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
24.50-0.33 (-1.33%)
As of 04:00PM EDT. Market open.
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    Valneva Successfully Completes Lot-to-Lot Consistency Trial for its Single-Shot Chikungunya Vaccine Candidate

    Saint Herblain (France), May 25, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the successful completion of the lot-to-lot Phase 3 trial of its single-shot chikungunya vaccine candidate, VLA1553. The final analysis included six-month follow-up data and confirmed the topline results reported in December 2021. The VLA1553-302 trial met its primary endpoint, demonstrating that three consecutively manufactured vaccine lots elicited equivalent imm

  • Zacks

    Dynavax (DVAX) Up as EMA Accepts Valneva's COVID-19 Vaccine MAA

    Dynavax (DVAX) gains as the EMA accepts partner Valneva's MAA for COVID-19 vaccine.

  • Motley Fool

    Why Dynavax Stock Blasted 16% Higher Today

    What happened Several days after experiencing a pleasant share price pop on good regulatory news, Dynavax (NASDAQ: DVAX) repeated the feat on Thursday. An important partner for the company reported an encouraging development that morning, also in the regulatory sphere.

Advertisement
Advertisement